期刊文献+

Emerging immunological concepts in the pathogenesis of myelodysplastic syndromes

Emerging immunological concepts in the pathogenesis of myelodysplastic syndromes
下载PDF
导出
摘要 The involvement of T-lymphocytes in the pathogenesis of myelodysplastic syndromes(MDS) is now well documented by relevant clinical and experimental findings.This brief review will focus on the T-cell repertoire pattern typical of MDS patients as well as on the potential role exerted by specific T-cell subsets in this context.Future investigations should further explore the specific role played by different T-cell subsets in the bone marrow milieu typical of MDS, further clarifying which of the described changes represent either an epiphenomenon or rather a real causative factor in the pathogenesis of these disorders. The involvement of T-lymphocytes in the pathogenesis of myelodysplastic syndromes(MDS) is now well documented by relevant clinical and experimental findings.This brief review will focus on the T-cell repertoire pattern typical of MDS patients as well as on the potential role exerted by specific T-cell subsets in this context.Future investigations should further explore the specific role played by different T-cell subsets in the bone marrow milieu typical of MDS, further clarifying which of the described changes represent either an epiphenomenon or rather a real causative factor in the pathogenesis of these disorders.
作者 Claudio Fozza
出处 《World Journal of Hematology》 2013年第2期13-15,共3页 世界血液学杂志
关键词 MYELODYSPLASTIC SYNDROMES T-CELLS T-CELL receptor REPERTOIRE Regulatory T cells Immunotherapy Myelodysplastic syndromes T-cells T-cell receptor repertoire Regulatory T cells Immunotherapy
  • 相关文献

参考文献1

二级参考文献15

  • 1Van Sandick JW, Boermeester MA, Gisbertz SS, et al.Lymphocyte subsets and T (h) 1/T (h)2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcome [J]. Cancer Immunol Immunother, 2003,52 (10):617-624.
  • 2Cho Y, Miyamoto M, Kato K, et al. CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma [J]. Cancer Res, 2003,63(7):1555-1559.
  • 3Derenzini M. The AgNORs [J]. Micron, 2000,31:117-120.
  • 4Sirri V, Roussel P, Hernandez-Verdun D. The AgNOR proteins: qualitative and quantitative changes during the cell cycle [J]. Micron, 2000,31: 121-126.
  • 5Rodriguez JM, Arias-Diaz J, Figueredo MA, et al.Lymphocyte subpopulations and surgery. The role of postoperative patenteral nutrition [ J ]. Nutr Hosp, 1994,9(5): 324-330.
  • 6Tsutsui S, Morita M, Kuwano H, et al. Influence of preoperative treatment and surgical operation on immune function of patients with esophageal carcinoma [J]. J Surg Oncol, 1992,49(3): 176-181.
  • 7Bentdal OH, Froland SS, Bosnes V, et al. Alterations in lymphocyte subsets in blood may predict resectability in carcinoma of cardia or oesophagus [J]. Cancer Lett, 1996,100(1-2): 133-138.
  • 8Tashiro T, Yamamori H, Takagi K, et al. Changes in immune function following surgery for esophageal carcinoma[J]. Nutrition, 1999,15(10) :760-766.
  • 9Heidecke CD, Weighardt H, Feith M, et al. Neoadjuvant treatment of esophageal cancer: immunosuppression following combined radiochemotherapy [J]. Surgery, 2002, 132(3):495-501.
  • 10Tsutsui S, Sonoda K, Sumiyoshi K, et al. Prognostic significance of immunological parameters in patients with esophageal cancer [J]. Hepatogastroenterology, 1996,43(9):501-509.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部